Role of calpain-1 in the inhibition of simvastatin on myocardial inflammation in diabetic rats

HAN Qian-qian, LU Mei-li, WANG Hong-xin, TANG Fu-tian, ZHANG Ying-jie

Chinese Journal of Clinical Anatomy ›› 2019, Vol. 37 ›› Issue (1) : 60-63.

Chinese Journal of Clinical Anatomy ›› 2019, Vol. 37 ›› Issue (1) : 60-63. DOI: 10.13418/j.issn.1001-165x.2019.01.013

Role of calpain-1 in the inhibition of simvastatin on myocardial inflammation in diabetic rats

  • HAN Qian-qian 1,2, LU Mei-li 1, WANG Hong-xin 1, TANG Fu-tian1 , ZHANG Ying-jie2
Author information +
History +

Abstract

Objective To investigate the role of calpain-1 in the inhibition of simvastatin on myocardial inflammation in diabetic rats. Methods Forty SD rats were randomly divided into 4 groups: blank control group (CON group), streptozotocin group (STZ group), simvastatin high dose (20 mg/kg) treatment group (STZ+SIM20 group) and low dose (10 mg/kg) treatment group (STZ+SIM10 group). After 12 weeks, the pathological change of myocardial tissue was observed by HE staining. The expression of p65 was detected by immunohistochemistry. The expression of calpain-1, p65 and IκBα was detected by Western Blot. Serum TNF-α, IL-6 content was detected by ELISA. Results Compared with the STZ group, the SIM treatment group had neatly arranged cardiomyocytes and decreased inflammatory cell infiltration. The expression of p65 and IκBα protein in the cytoplasm was increased, and the expression of calpain-1, TNF-α, IL-6 and nucleus p65 in the nucleus was decreased. Conclusion Simvastatin has a protective effect on myocardial inflammation in diabetic rats, and its mechanism may be related to the inhibition of myocardial calpain-1 expression.

Key words

Simvastatin /  Diabetic rats /  Calpain-1 /  Inflammation

Cite this article

Download Citations
HAN Qian-qian, LU Mei-li, WANG Hong-xin, TANG Fu-tian, ZHANG Ying-jie. Role of calpain-1 in the inhibition of simvastatin on myocardial inflammation in diabetic rats[J]. Chinese Journal of Clinical Anatomy. 2019, 37(1): 60-63 https://doi.org/10.13418/j.issn.1001-165x.2019.01.013

References

[1]  Zhang B, Shen Q, Chen Y, et al. Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy[J]. Sci Rep, 2017, 7: 44239.
[2]  Miyazaki T, Koya T, Kigawa Y, et al. Calpain and atherosclerosis[J]. J Atheroscler Thromb, 2013, 20(3): 228-237.
[3] Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes[J]. Circ Res, 2016, 118(11): 1808-1829.
[4]  Liu J, Shen Q, Wu Y. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway[J]. Life Sci, 2008, 82(19-20): 991-996.
[5] Al-Rasheed NM, Al-Rasheed NM, Hasan IH, et al. Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats[J]. Oxid Med Cell Longev, 2017, 2017: 1092015.
[6]  陈晨 ,王洪新,张英杰,等. 黄芪甲苷通过AMPK/mTOR信号通路改善STZ诱导的糖尿病大鼠的心肌损害[J]. 中药药理与临床, 2018, 34(3): 80-85.
[7] Vulesevic B, Mcneill B, Giacco F, et al. Methylglyoxal-induced endothelial cell  loss and inflammation contribute to the development of diabetic cardiomyopathy[J]. Diabetes, 2016, 65(6): 1699-1713.
[8] Othman AI, El-sawi MR, El-missiry MA, et al. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats[J]. Biomed Pharmacother, 2017, 94: 362-373.
[9]  Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure[J]. Heart, 2007, 93(8): 903-907.
[10] Yin M, Liu Q, Yu L, et al. Downregulations of CD36 and calpain-1, inflammation, and atherosclerosis by simvastatin in apolipoprotein E knockout mice[J]. J Vasc Res, 2017, 54(3): 123-130.
[11]Choi H, Myung K. Calcitriol enhances fat synthesis factors and calpain activity in co-cultured cells[J]. Cell Biol Int, 2014, 38(8): 910-917.
[12]Li Q, Harraz MM, Zhou W, et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes[J]. Mol Cell Biol, 2006, 26(1): 140-154.
[13]Li Y, Ma J, Zhu H, et al. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes[J]. Diabetes, 2011, 60(11): 2985-2994.
[14]Li X, Luo R, Chen R, et al. Cleavage of IκBα by calpain induces myocardial NF-kappaB activation, TNF-alpha expression, and cardiac dysfunction in septic mice[J]. Am J Physiol Heart Circ Physiol, 2014, 306(6): H833-H843.
[15]O'neill WC, Lomashvili KA, Malluche HH, et al. Treatment with pyrophosphate inhibits uremic vascular calcification[J]. Kidney Int, 2011, 79(5): 512-517.

Accesses

Citation

Detail

Sections
Recommended

/